Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI

NCT05594355 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment (MCI)

Interventions

DRUG: TEBOFORTAN

Sponsor

Fundació ACE Institut Català de Neurociències Aplicades